Evolution of immune infiltration and immune triad formation across early melanoma progression
Tumor-infiltrating lymphocytes (TIL) in melanoma are a clinically important prognostic marker and are routinely used to inform patient care. However, when immune recognition of transformed melanocytes begins and how it evolves during early melanoma progression is not well understood. Using spatial transcriptomics and a unique cohort of patient-matched lesions representing multiple stages of early…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
